Various types Pre-clinical anti CD-47 therapy Institute: Telethon Kids Institute Recipient: Dr Raelene Endersby and Professor Nick Gottardo Funding: $98,716 July 2021 to June 2022
Neuroblastoma Enhanced polyamine depletion for aggressive childhood cancers Institute: Children’s Cancer Institute Recipient: Professor Michelle Haber Funding: $239,995 July 2019 to June 2023
Medulloblastoma Application of gene-silencing nanodrugs to inhibit medulloblastoma growth Institute: Children’s Cancer Institute Recipient: Associate Professor Joshua McCarroll Funding: $298,554 July 2019 to June 2023
Various types Reboot-Kids Institute: Sydney Children’s Hospital, Kids Cancer Centre Recipient: Dr Jennifer Cohen and Professor Claire Wakefield Funding: $249,972 July 2019 to June 2023
Various types International clinical trials support Recipient: Australian and New Zealand Children’s Haematology/Oncology Group Funding: $1,075,000 July 2015 to June 2023
Various types Personalised Medicine: Zero Childhood Cancer Recipient: Professor Michelle Haber Institute: Children’s Cancer Institute Funding: $2,287,250 July 2014 to June 2023
Osteosarcoma Intraoperative immunotherapy to prevent relapse in soft tissue sarcoma Institute: Telethon Kids Institute Recipient: Dr W Joost Lesterhuis Funding: $197,525 July 2019 to June 2022
Neuroblastoma “Cage fighting" with neuroblastoma Institute: Macquarie University Recipient: Dr Andrew Care Funding: $63,926 July 2019 to June 2022
Medulloblastoma Personalised targeted therapy for adolescent and young adult medulloblastoma patients Recipient: Dr Elizabeth Hovey Institute: Nelune Comprehensive Cancer Centre Funding: $167,169 July 2019 to June 2022
DIPG Targeting Polo-like kinase 1 as a novel therapeutic opportunity for diffuse intrinsic pontine glioma Recipient: Associate Professor David Ziegler Institute: Sydney Children's Hospital Funding: $278,282 July 2019 to June 2022
Medulloblastoma Exploiting CDK4/6 inhibition to treat medulloblastoma Recipient: Professor Brandon Wainwright Institute: University of Queensland Funding: $196,207 July 2019 to June 2022
Leukaemia Targeting the NAD pathway as a new therapeutic strategy for high-risk leukaemia in children Recipient: Dr Michelle Henderson Institute: University of NSW Funding: $138,179 July 2019 to June 2022
Various types Understanding the genetic basis of chemotherapy-induced cardiomyopathy Recipient: Dr Rachel Conyers Institute: The Murdoch Children’s Research Institute Funding: $583,072 July 2018 to June 2022
Leukaemia IntReALL-HR Recipient: Associate Professor Tamas Revesz Institute: Women's and Children's Hospital, Adelaide Funding: $416,422 July 2018 to June 2022
Various types New state-wide Children’s and Adolescent/Young Adult Cancer Clinical Trials Unit Recipient: Associate Professor John Heath Institute: Royal Hobart Hospital Funding: $308,517 July 2017 to June 2022
Leukaemia Investigating drug resistance and genetic changes in Ph-like ALL in adolescents Recipient: Dr Susan Heatley Institute: South Australian Health & Medical Research Institute Funding: $398,146 July 2016 to June 2022
Leukaemia Pre-clinical development of novel immune therapy for paediatric cancers Recipient: Dr Alla Dolnikov Institute: Sydney Children's Hospital, Randwick Funding: $480,000 July 2016 to June 2022
Various types Impact of treatment on late effects and survivorship on childhood cancer survivors Recipient: Professor Natasha Nassar Institute: University of Sydney Funding: $39,578 July 2019 to June 2021
Various types Developing treatments for vincristine-induced neuropathy Recipient: Associate Professor Irina Vetter Institute: The University of Queensland Funding: $255,978 July 2019 to June 2021
Testicular Development of a non-invasive diagnostic and prognostic assay for adolescent testicular cancer Recipient: Dr Cassy Spiller Institute: The University of Queensland Funding: $50,000 July 2019 to June 2021
DIPG Epigenetic targeted therapy in DIPG Recipient: Associate Professor David Ziegler Institute: Children’s Cancer Institute Funding: $251,428 July 2019 to June 2021
Neuroblastoma MicroRNA drugs for the treatment of neuroblastoma Recipient: Associate Professor Alexander Swarbrick Institute: Garvan Institute of Medical Research Funding: $308,270 July 2018 to June 2021
Various types The NORTH Trial Recipient: Dr Paul Wood Institute: ANZCHOG Funding: $61,420 July 2018 to June 2021
Various types National Tumour Biobanking Network Recipient: Professor Jennifer Byrne and Rose Boutros Funding: $482,891 July 2015 to June 2021
Various types 3D printers and mini-brains Recipient: Associate Professor Geraldine O’Neill Institute: The Children’s Hospital at Westmead Funding: $119,821 July 2019 to June 2020
Leukaemia Overcoming therapeutic resistance in high risk ALL using novel BH3 mimetic Recipient: Dr Diane Hanna Institute:The Walter and Eliza Hall Institute Funding: $100,000 July 2019 to June 2020
Medulloblastoma Using targeted chemotherapies to reduce intensity of radiotherapy in medulloblastoma Recipient: Dr Nick Gottardo Institute: Telethon Kids Institute Funding: $256,342 July 2018 to June 2020
Various types New therapies for incurable paediatric brain tumours Recipient: Professor Brandon Wainwright Institute: The Institute of Molecular Bioscience Funding: $224,936 July 2018 to June 2020
Leukaemia Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia Recipient: Dr Rishi Kotecha Institute: Telethon Kids Institute Funding: $445,695 July 2017 to June 2020
Leukaemia Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic Recipient: Professor Richard Lock Institute: Children’s Cancer Institute Funding: $103,571 July 2017 to June 2020
Various types Ready, Steady, School Recipient: Dr Joanna Fardell Institute: UNSW Australia Funding: $523,308 July 2016 to June 2020
Neuroblastoma Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma Recipient: Dr Daniel Carter Institute: UNSW Australia Funding: $296,428 July 2016 to June 2020
Osteosarcoma Exploring better and safer treatments for osteosarcoma Recipient: Associate Professor Christine Hawkins Institute: La Trobe University Funding: $382,713 July 2016 to June 2020
Leukaemia Therapeutic targeting transcriptional addiction in paediatric leukaemias Recipient: Professor Ricky Johnstone Institute: Peter MacCallum Cancer Centre Funding: $496,282 July 2016 to June 2020
DIPG Synthetic retinoid therapy for diffuse intrinsic pontine glioma Recipient: Associate Professor David Ziegler Institute: Children’s Cancer Institute Funding: $200,000 July 2016 to June 2020
Various types Development of CAR T cell immunotherapies for paediatric patients Recipient: Dr Belinda Kramer and Dr Geoff McCowage Institute: The Children’s Hospital at Westmead Funding: $4,309,610 July 2010 to June 2020
Medulloblastoma Development of personalised medicine approaches to treat medulloblastoma Recipient: Professor Bryan Day Institute: QIMR Berghofer Medical Research Institute Funding: $263,960 July 2016 to June 2019
DIPG Novel therapies for diffuse intrinsic pontine glioma (DIPG) Recipient: Associate Professor David Ziegler Institute: Children’s Cancer Institute Funding: $583,142 July 2016 to June 2019
Medulloblastoma Improving chemotherapy regimens for medulloblastoma Recipient: Dr Nick Gottardo Institute: Telethon Kids Institute Funding: $252,987 July 2016 to June 2018
Various types Next gen sequencing to identify gene mutations in childhood cancer patients Recipient: Professor Jennifer Byrne and Dr Luciano Dalla-Pozza Institute: The Children's Hospital at Westmead Funding: $75,000 July 2017 to June 2018
Medulloblastoma New therapeutic targets for paediatric medulloblastoma Recipient: Dr Bryan Day Institute: QIMR Berghofer Medical Research Institute Funding: $208,549 July 2014 to June 2015 and July 2017 to June 2018
Medulloblastoma Novel targets to treat medulloblastoma Recipient: Professor Brandon Wainwright Institute: Institute for Molecular Bioscience Funding: $260,420 July 2016 to June 2018
Leukaemia Personalised disease monitoring in childhood AML Recipient: Dr Andrew Moore Institute: University of Queensland Diamantina Institute Funding: $474,591 July 2014 to June 2019
Various types Re-engage Recipient: Professor Claire Wakefield Institute: UNSW Australia Funding: $300,381 July 2015 to June 2018
Leukaemia Improving treatments for infant acute lymphoblastic leukaemia (iALL) Institute: Telethon Kids Institute Recipient: Professor Ursula Kees and Dr Rishi Kotecha Funding: $475,217 July 2014 to June 2018
Neuroblastoma International DFMO clinical trial Institute: Children’s Cancer Institute Recipient: Associate Professor David Ziegler Funding: $448,142 June 2014 to July 2018
Various types Drug discovery project Institute: UNSW Australia Recipient: Professor Peter Gunning Funding: $5,884,000 July 2010 to June 2018
Various types Treatment of solid paediatric cancers with tropomyosin targeted therapy Institute: Nationwide Children’s Hospital, Ohio Recipient: Professor Timothy Cripe Funding: $600,000 July 2011 to June 2018
Various types Tumour Bank at CHW Institute: The Children’s Hospital at Westmead Recipient: Associate Professor Daniel Catchpoole Funding: $2,425,000 July 2010 to June 2018
Various types Developing novel immunotherapies for childhood blood cancers Institute: University of Queensland Diamantina Institute Recipient: Dr Andrew Moore Funding: $ 87,000 from July 2016 to June 2017
Neuroblastoma Stathmin regulation of microRNA expression in neuroblastoma cells Institute: Children’s Cancer Institute Recipient: Professor Maria Kavallaris Funding: $820,173 July 2009 to June 2017
Various types Bio-banking and personalised medicine software platform Recipient:Professor Glenn Marshall Institute: Kids Cancer Alliance Funding: $240,000 July 2015 to June 2016
Medulloblastoma Improving the cure rates of childhood brain cancer Institute: Telethon Kids Institute Recipient: Dr Nick Gottardo Funding: $64,562 July 2015 to June 2016
Neuroblastoma Switching off genes Institute: Garvin Institute of Medical Research Recipient: Dr Alex Swarbrick Funding: $385,000 July 2012 to June 2016
Neuroblastoma Clinical trial of new treatment for relapsed neuroblastoma Institute: Children's Cancer Institute Recipient: Professor Michelle Haber Funding: $300,000 July 2013 to June 2016
Various types Evaluating potential side effects of anti-tropomyosins Institute: University of NSW Recipient: Professor Edna Hardeman Funding: $550,000 July 2011 to June 2016
Neuroblastoma Cytoskeletal regulation of adhesion dynamics in neuroblastoma metastases Institute: The Children's Hospital at Westmead Recipient: Associate Professor Geraldine O'Neill Funding: $500,000 July 2010 to June 2016
Neuroblastoma Role of microRNAs in neuroblastoma Institute: Centre for Cancer Biology Recipient: : Associate Professor Gregory Goodall and Dr Yeesim Khew-Goodall Funding: $550,000 July 2010 to June 2016
Neuroblastoma Understanding neuroblastoma cell migration Institute: Institute for Molecular Bioscience Recipient: Professor Alpha Yap Funding: $623,000 July 2009 to June 2016
Various types Determine how disruption of Tm5NM1 leads to programed cell death Institute: University of NSW Recipient: Professor Peter Gunning Funding: $450,000 July 2010 to June 2015
Neuroblastoma Muscle stem cell Institute: University of NSW Recipient: Professor Peter Gunning Funding: $300,000 July 2010 to June 2014
Various types Modelling paediatric brain tumours in Drosophila Institute: Peter MacCallum Cancer Centre Recipient: Associate Professor Helena Richardson Funding: $400,000 July 2009 to June 2014
Various types Improving treatments for adolescents and young adults Institute: Murdoch Children’s Research Institute Recipient: Dr Michael Coory Funding: $50,000 July 2012 to June 2013
Neuroblastoma Neuroblastoma sensitivity to chemotherapy Institute: St Vincent's Institute Recipient: Dr Ora Bernard Funding: $300,000 July 2009 to June 2013
Various types Translational research at the Biospecimens Research Group and Tumour Bank Institute: The Children's Hospital at Westmead Recipient: Dr Daniel Catchpoole Funding: $50,000 July 2010 to June 2011